A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2006
11/09/2006	US20060252765 Corneal perception recovery drug containing amide compound
11/09/2006	US20060252760 Farnesyl transferase inhibitors
11/09/2006	US20060252732 Blood vessel-growth promoter
11/09/2006	US20060252718 Sphingolipids polyalkylamine conjugates for use in transfection
11/09/2006	US20060252717 Sphingoid polyalkylamine conjugates for vaccination
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252703 Method for treating cancer
11/09/2006	US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006	US20060252677 Postsynaptic proteins
11/09/2006	US20060252104 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
11/09/2006	US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	CA2613169A1 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors
11/09/2006	CA2607727A1 Cyanopyridine derivative and use thereof as medicine
11/09/2006	CA2607524A1 Agent for prophylaxis and treating of pancreatitis
11/09/2006	CA2607506A1 Novel lactam compound
11/08/2006	EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1719771A1 Pyrazoloquinolone derivative and use thereof
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1719757A1 Bicyclo derivative
11/08/2006	EP1719526A2 Pharmaceutical combinations comprising a P2T receptor antagonist and another anti-thrombotic agent
11/08/2006	EP1719525A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
11/08/2006	EP1719524A1 Nuclear transfer promoter for rac protein and method of screening the same
11/08/2006	EP1719522A1 Medicinal composition comprising TCF-II
11/08/2006	EP1719518A1 Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals
11/08/2006	EP1719512A2 Sarsasapogenin and smilagenin for treating cognitive dysfunctions
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1719506A1 Gene expression controlling agent
11/08/2006	EP1718762A1 Antisense oligonucleotide modulation of stat3 expression
11/08/2006	EP1718641A2 Benzimidazole derivative and its use as aii receptor antagonist
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1265920B1 Angiogenesis-associated proteins, and nucleic acids encoding the same
11/08/2006	EP1242438B1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
11/08/2006	EP1227791B1 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition
11/08/2006	EP1225878B1 Rar-gamma selective retinoid agonists for the treatment of emphysema
11/08/2006	EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006	CN1860097A Amide type carboxamide derivative
11/08/2006	CN1857720A Freeze dried human cell fibronection powder and its preparing method
11/08/2006	CN1857641A Externally applied medicine for cutting therapy
11/08/2006	CN1857640A Arborvitae seed preparation and its preparing process
11/08/2006	CN1857600A Chinese medicine preparation for treating acute and chronic appendicitis
11/08/2006	CN1857590A Medicine for mediating blood cell to raise immunity
11/08/2006	CN1857558A Chinese medicine for treating children's hyperkinetic syndrome and its preparing method
11/08/2006	CN1857552A Recuperating and health preserving fumigant bag
11/08/2006	CN1857437A Method for processing Chinese medicine white peony root
11/08/2006	CN1857402A Decoction with functions of benefiting Qi, promoting blood circulation and promoting tissue regeneration for taking after uterine apoxesis
11/08/2006	CN1857379A Preparing method of body resistance-strengthening ginseng-astragalus injection
11/08/2006	CN1857374A Jade screen micropill and its preparing method
11/08/2006	CN1857339A Proctoptosis treating fumigant and its preparing method
11/08/2006	CN1857326A Lactobacillus probiotics preparation and its preparing method and application
11/08/2006	CN1857315A Tortoise plastron extract for promoting growth of marrow mesenchyme stem cell and its preparing method and applciation
11/08/2006	CN1284088C 访问控制系统 Access Control System
11/08/2006	CN1283778C Culture of Chansi mould strains and extraction and use of anagentic compound therefrom
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283658C Proline ester and preparation containing the same for percutaneous administration
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006	CN1283621C Alkyl urea vitamin A protagonist I
11/08/2006	CN1283611C Novel fatty acid analogous
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/08/2006	CN1283315C Bovine respiratory coronavirus as a vaccine
11/08/2006	CN1283314C Antiparkinsonism drugs
11/08/2006	CN1283304C Quality control method for composite Chinese medicine for treating bloat
11/08/2006	CN1283283C Tendon-extending bone-penetrating spray of and its preparing method
11/08/2006	CN1283282C Chinese traditional medicine for treating appendicitis
11/08/2006	CN1283252C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
11/08/2006	CN1283250C Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/08/2006	CN1283248C Combinations comprising epothilones and pharmaceutical uses thereof
11/08/2006	CN1283240C Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders
11/07/2006	US7133814 System and methods for optimized drug delivery and progression of diseased and normal cells
11/07/2006	US7132560 Reacting N-methacryloyl-4-cyano-3-trifluoromethylaniline with mono-perphthalic acid to form 4-cyano-N-(2,3-epoxy-2-methylpropionyl)-3-trifluoromethylaniline
11/07/2006	US7132553 Inhibitor is a (2-amino-(optionally -1-oxo)-3-thiopropyl)--5,6,7,8-tetrahydroimidazo[1,2a]pyrazine derivative or its disulfide dimer, e.g., (2-amino-1-oxo-3-thiopropyl)-8-(cyclohexylmethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine
11/07/2006	US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimers, Parkinsons, Lesche-Nyhane, Wilsons, and Tourettes syndrome
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132506 Peptide having osteogenetic activity and osteogenetic accelerator containing the same
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132451 Inhibition of TNF-α-initiated neutrophil response
11/07/2006	US7132449 useful for the therapeutic treatment of Trypanosoma cruzi infection
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006	US7132438 Benzimidazole derivatives

1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 1564